Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
LACTOSE.BOthis companyLactose (India) Limited	₹104.40	16.68×	1.56×	0.62×	8.37×	-41.4%	14.5%	7.7%	3.7%	9.4%	6.7%	-8.7%	0.96×	3.17×	2.48×	1.1×	0.0%	4	—	3	B
BAFNAPH.NSBafna Pharmaceuticals Limited	₹472.80	23.31×	2.69×	1.72×	14.21×	-102.8%	13.4%	6.6%	7.4%	11.5%	7.2%	-5.1%	0.39×	1.71×	2.7×	1.57×	0.0%	5	—	1	C-
BPLPHARMA.BOBharat Parenterals Limited	₹1,813.35	-22.72×	0.58×	0.54×	12.63×	-722.6%	15.2%	-5.3%	-2.4%	-2.5%	-3.8%	-5.6%	0.45×	5.29×	-1.47×	1.97×	0.4%	3	3.1	2	C
CORALAB.BOCoral Laboratories Limited	₹533.50	8.08×	0.63×	1.54×	2.52×	7.4%	37.6%	15.2%	19.1%	7.8%	4.3%	-6.3%	0.02×	-2.68×	76.29×	6.48×	0.4%	2	—	3	B
LASA.NSLasa Supergenerics Limited	₹4.22	-0.83×	0.57×	1.13×	-1.34×	-306.6%	-27.4%	-53.2%	-135.6%	-68.7%	-22.1%	0.0%	0.2×	-0.34×	-34.66×	0.62×	0.0%	2	—	2	C
MAKERSL.BOMakers Laboratories Limited	₹267.10	33.88×	1.09×	0.57×	5.78×	-119.2%	39.1%	7.3%	1.7%	3.2%	5.3%	12.9%	0.08×	0.37×	13.24×	2.56×	0.0%	4	—	2	C+
Peer median	—	8.08×	0.63×	1.13×	5.78×	-119.2%	15.2%	6.6%	1.7%	3.2%	4.3%	-5.1%	0.2×	0.37×	2.7×	1.97×	0.0%	3	3.1	2	—